Sarepta Therapeutics Helps Biotech ETFs Buck Market Trend
Biotechnology sector-related exchange traded funds were among the few areas of the markets that shook off the tariffs-talk volatility and was still…
BBP
Rising Rates May Hurt Small-Cap Biotech ETF Valuations
The Federal Reserve has hiked interest rates for the second time in a decade and plans to raise rates three more times…
Biotech ETFs Will Enjoy a More Favorable Environment
Now that the political overhang on the markets has more or less abated, biotechnology stocks and sector-related exchange traded funds could enjoy…
ETF Winners and Losers of President-Elect Trump
Biotechnology and pharmaceutical sector ETFs were the clear winners as Republicans swept the U.S. elections, easing concerns Democrats would implement controls on…
BBP: An Outperforming Biotechnology ETF
The BioShares Biotechnology Products Fund (NasdaqGM: BBP) has capitalized on a string of acquisitions and outperformed other biotechnology- and pharmaceuticals-related exchange traded…
Biotech ETFs Rally as Earnings Boost Optimism
U.S. equities strengthened Wednesday with biotechnology stocks and sector-related exchange traded funds leading the charge on better-than-expected second quarter results. On Wednesday,…
A Biotech ETF Proving Immune to Hawkish Fed Policy Changes
Biotechnology exchange traded funds are still scuffling on a year-to-date basis, but some members of that group have recently been showing signs…
Hit The Lab With These 17 Biotech ETFs
The time to buy, regardless of sector, is usually when a particular group falls out of favor, not when it has been…
Why This Biotech ETF Keeps Surging
Ten biotechnology exchange traded funds hit all-time highs Wednesday, an impressive number when considering that represents about two-thirds of the biotech ETF…
Investors Were Prepared for the Biotech Breakout
When the top four sector exchange traded funds on a year-to-date basis and six of the top 10 are biotechnology funds, talking…
BioShares Biotech ETFs Boost Lineups, Increase Diversity
Generally speaking, the biotechnology exchange traded funds trade has been relatively easy. Save for bumps in the road here and there, investors…
A New Biotech ETF Could Challenge Established Rivals
It has been a stellar run for the legacy biotechnology exchange traded funds. The legacy biotechnology ETFs, including the largest, the iShares…
Biotech ETF Run not Over Yet, Says Analyst
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), First Trust NYSE Arca Biotechnology Index Fund (NYSEArca: FBT) and the SPDR S&P Biotech ETF…
Reasons to bet on new Breed Biotech ETFs
By their standards, biotechnology exchange traded funds have been quiet in recent weeks, though the obituaries written on these ETFs by some…